Protective effect of Rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system
dc.contributor.author | Abbas, N. | en |
dc.contributor.author | Zou, L. P. | en |
dc.contributor.author | Pelidou, S. H. | en |
dc.contributor.author | Winblad, B. | en |
dc.contributor.author | Zhu, J. | en |
dc.date.accessioned | 2015-11-24T18:55:56Z | |
dc.date.available | 2015-11-24T18:55:56Z | |
dc.identifier.issn | 0891-6934 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18958 | |
dc.rights | Default Licence | - |
dc.subject | Animals | en |
dc.subject | Anti-Inflammatory Agents, Non-Steroidal/administration & dosage/therapeutic use | en |
dc.subject | Chemokine CCL2/biosynthesis | en |
dc.subject | Chemokine CCL4 | en |
dc.subject | Chemokine CXCL2 | en |
dc.subject | Chemokines/biosynthesis | en |
dc.subject | Down-Regulation/drug effects | en |
dc.subject | Humans | en |
dc.subject | Inflammation Mediators/metabolism | en |
dc.subject | Interferon-gamma/biosynthesis | en |
dc.subject | Interleukin-4/biosynthesis | en |
dc.subject | Macrophage Inflammatory Proteins/biosynthesis | en |
dc.subject | Male | en |
dc.subject | Myelin P2 Protein/immunology | en |
dc.subject | Neuritis, Autoimmune, Experimental/*drug therapy/*immunology/pathology | en |
dc.subject | Peripheral Nerves/drug effects/immunology/pathology | en |
dc.subject | Phosphodiesterase Inhibitors/administration & dosage/*therapeutic use | en |
dc.subject | Rats | en |
dc.subject | Rats, Inbred Lew | en |
dc.subject | Rolipram/administration & dosage/*therapeutic use | en |
dc.subject | Up-Regulation/drug effects | en |
dc.title | Protective effect of Rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system | en |
heal.abstract | Rolipram, a phosphodiesterase type 4 inhibitor, is reported to have anti-inflammatory effects. It can markedly downregulate antigen-driven T cell proliferation and suppress TNF-(alpha and TNF-beta production in vitro and in vivo, which have led to its use in the treatment of a number of autoimmune disorders including experimental autoimmune encephalomyelitis (EAE) and experimental autoimmune neuritis (EAN). EAN is a CD4+ T cell-mediated demyelinating autoimmune disease of peripheral nervous system (PNS) that represents an animal model for the study of the immunopathogenesis and immunotherapy of Guillain-Barre syndrome (GBS) in human. In the previous study, we reported that suppression of EAN by Rolipram was associated with down-regulated myelin antigen-induced T cell responses as well as downregulated IFN-gamma and TNF-alpha production. Here we report that EAN induced in Lewis rats by inoculation with the PNS P2 protein peptide 57-81 and Freund's complete adjuvant (FCA), was strongly suppressed by Rolipram administered twice daily intraperitoneally from day 9 post immunization (p.i.), i.e. after onset of clinical EAN to day 18 p.i. This clinical effect was associated with dose-dependent down-regulated production of IFN-gamma and the chemokines macrophage inflammatory protein-1 alpha (MIP-1 alpha, MIP-2 and monocyte chemotactic protein-1(MCP-1) as well as up-regulated IL-4 production in sciatic nerve sections from Rolipram-treated EAN rats at maximum of clinical EAN, i.e. on day 14 p.i.. These findings suggest that Rolipram may be useful in certain T cell-dependent autoimmune diseases and inflammatory neuropathies. These observations call for further studies on the potential role of Rolipram in the treatment of autoimmune diseases. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/11078155 | - |
heal.journalName | Autoimmunity | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2000 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: